Myriad Genetics, Inc.’s recently made public that its Officer Ancona Margaret acquired Company’s shares for reported $0.32 million on Aug 21 ’24. In the deal valued at $27.82 per share,11,538 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DIAZ PAUL J sold 15,000 shares, generating $400,800 in total proceeds. Upon selling the shares at $26.72, the President and CEO now owns 977,378 shares.
Before that, Muzzey Dale sold 2,100 shares. Myriad Genetics, Inc. shares valued at $54,961 were divested by the Chief Scientific Officer at a price of $26.17 per share. As a result of the transaction, Muzzey Dale now holds 108,013 shares, worth roughly $2.82 million.
Morgan Stanley initiated its Myriad Genetics, Inc. [MYGN] rating to an Equal-weight in a research note published on September 19, 2024; the price target was $32. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Overweight”‘ rating. Scotiabank began covering MYGN with “Sector outperform” recommendation on June 27, 2024.
Price Performance Review of MYGN
On Monday, Myriad Genetics, Inc. [NASDAQ:MYGN] saw its stock fall -1.25% to $26.14. Over the last five days, the stock has lost -4.56%. Myriad Genetics, Inc. shares have risen nearly 36.57% since the year began. Nevertheless, the stocks have risen 68.75% over the past one year. While a 52-week high of $29.30 was reached on 09/18/24, a 52-week low of $13.82 was recorded on 01/08/24. SMA at 50 days reached $27.32, while 200 days put it at $23.50.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 25.83, which if violated will result in even more drops to 25.52. On the upside, there is a resistance level at 26.52. A further resistance level may holdings at 26.91. The Relative Strength Index (RSI) on the 14-day chart is 42.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.59, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.94%. Stochastics %K at 13.14% indicates the stock is a buying.
How much short interest is there in Myriad Genetics, Inc.?
A steep rise in short interest was recorded in Myriad Genetics, Inc. stocks on 2024-09-13, growing by 62432.0 shares to a total of 3.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 3.88 million shares. There was a rise of 1.58%, which implies that there is a positive sentiment for the stock.
